Results 151 to 160 of about 25,608 (226)

Clinical Characteristics and Management of Non-Tuberculous Mycobacterial Skin and Soft Tissue Infections: A Retrospective Cohort Study. [PDF]

Open Forum Infect Dis
Peeters W, van Lier C, van Ingen J, van Houdt C, van Crevel R, van Hees C, Bax H, van den Reek J, van Laarhoven A.   +8 more
europepmc   +1 more source

Quantifying uncertainty of tuberculosis drug susceptibility range from single-microplate test. [PDF]

MethodsX
Postnikov EB, Lavrova AI.
europepmc   +1 more source

Untersuchungen zu Diagnostik und Therapie des Buruli Ulkus mittels tropenadaptierter Labormethoden in endemischen Regionen [PDF]

, 2009
Bretzel, Gisela
core  

Investigating the Mechanism of Antimycobacterial and Antiproliferative Activity of (E)-N'-Benzylidenepyrazine-2-Carbohydrazides and their Derivatives. [PDF]

ChemMedChem
Houngbedji PA, Nawrot DE, Janďourek O, Konečná K, Novák M, Paterová P, Bárta P, Rambaher MH, Novotná E, Castellano C, Mori M, Meneghetti F, Záhorszká M, Korduláková J, Zitko J.   +14 more
europepmc   +1 more source

Fullerene Gallium Phosphonate Shows Antimycobacterial Effect Against <i>Mycobacterium avium</i>. [PDF]

Int J Mol Sci
Yoon S, Sasaninia K, Era IH, Dhama S, Mohan AS, Patel A, Nguyen L, Karapetyan A, Sy C, Yedgarian N, Newman N, Bi X, Baudry M, Yang PR, Venketaraman V.   +14 more
europepmc   +1 more source

Harnessing Actinobacteria secondary metabolites for tuberculosis drug discovery: Historical trends, current status and future outlooks. [PDF]

Nat Prod Bioprospect
de Almeida LLC, Fernandes SP, de Oliveira GD, da Silveira Silva M, de Souza TA, Rodrigues-Junior VS, Cibulski SP.   +6 more
europepmc   +1 more source

Retro-inversion imparts antimycobacterial specificity to host defense peptides. [PDF]

Nat Commun
Glossop HD, Gebretsadik G, Sultana S, Biswas D, Schacht NA, Yennawar NH, Rather MA, Baughn AD, Medina SH.   +8 more
europepmc   +1 more source

Clinical outcomes and adverse events of nontuberculous mycobacterial lung disease treated at an Italian tertiary referral center. [PDF]

Sci Rep
Carli SM, Mencarini P, Licata MAV, Musso M, Cerva C, Mastrobattista A, Vittozzi P, Mosti S, Nisii C, Mazzarelli A, Navarra A, De Carli G, Ianniello S, Palmieri F, Gualano G.   +14 more
europepmc   +1 more source

Verapamil Suppresses the Development of Resistance Against Anti-Tuberculosis Drugs in Mycobacteria. [PDF]

Int J Mol Sci
Liu K, Buitenhek E, Kuijl CP, Mulla Y, Luirink J, Bald D.   +5 more
europepmc   +1 more source